AKT1 and idiopathic pulmonary fibrosis: PI3K/AKT signaling, known for its role in the regulation of key fibrotic processes such as alveolar cell apoptosis, epithelial‐mesenchymal transition (EMT) and myofibroblast differentiation, has attracted significant attention in the recent years as a promising therapeutic target in IPF.